Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
Topic / Pathology
- Parkinson's Disease
Objectives
To have more informations, click on the link below:
https://clinicaltrials.gov/ct2/show/NCT03624920?term=theranexus&cond=Parkinson&draw=2&rank=1
Sponsor
Theranexus
Investigator
Pr Jean-Christophe Corvol
Scientific publication(s)
-
Corvol JC et al. THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial. Mov Disord. 2021 Oct 28.
Status
Published results
